CHA2DS2-VASc calculations in patients with atrial fibrillation receiving oral anticoagulants in Scotland
Zeng, Wenjie and Mueller, Tanja and Godman, Brian and Alvarez-Madrazo, Samantha and Bennie, Marion (2017) CHA2DS2-VASc calculations in patients with atrial fibrillation receiving oral anticoagulants in Scotland. International Journal of Population Data Science, 1 (1). 267.
|
Text (Wenjie-etal-IJPDS-2017-CHA2DS2-VASc-calculations-in-patients-with-atrial-fibrillation-receiving-oral-anticoagulants)
Wenjie_etal_IJPDS_2017_CHA2DS2_VASc_calculations_in_patients_with_atrial_fibrillation_receiving_oral_anticoagulants.pdf Final Published Version License: ![]() Download (213kB)| Preview |
Abstract
Patients with atrial fibrillation (AF) have an increased risk of developing stroke, and oral anticoagulants (OACs) are commonly used in stroke prevention. The CHA2DS2-VASc score has been proved to be a simple and effective tool for stroke risk assessment which guides the selection of treatment with OACs. This score is calculated using disease diagnoses; however, a range of different versions exist, making comparability questionable.The aim of this study was to compare CHA2DS2-VASc scores in OAC treated patients with a hospital-confirmed diagnosis of AF in Scotland using different subsets of ICD-10 codes.
Creators(s): |
Zeng, Wenjie, Mueller, Tanja ![]() ![]() | Item type: | Article |
---|---|
ID code: | 63179 |
Keywords: | atrial fibrillation, oral anticoagulants, Scotland, AF, stroke, Pharmacy and materia medica, Pharmacology, Toxicology and Pharmaceutics (miscellaneous) |
Subjects: | Medicine > Pharmacy and materia medica |
Department: | Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences |
Depositing user: | Pure Administrator |
Date deposited: | 05 Feb 2018 12:14 |
Last modified: | 17 Feb 2021 02:42 |
URI: | https://strathprints.strath.ac.uk/id/eprint/63179 |
Export data: |